The genetics of generalized vitiligo

Current Directions in Autoimmunity

Volumn 10, Issue , 2008, Pages 244-257

  Spritz, R ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; AUTOIMMUNE DISEASE; GENETIC LINKAGE; GENETICS; GENOME; HUMAN; IMMUNOLOGY; MELANOCYTE; PATHOLOGY; PIGMENTATION; REVIEW; VITILIGO;

ANIMALS; AUTOIMMUNE DISEASES; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); MELANOCYTES; PIGMENTATION; VITILIGO;

EID: 42249102012     PISSN: 14222132     EISSN: 16622936     Source Type: Book Series    
DOI: 10.1159/000131501     Document Type: Review

References (75)

1. Nordlund JJ, Ortonne J-P, LePoole IC: Vitiligo vulgaris; in Nordlund JJ, Boissy RE, Hearing VJ, King RA, Oetting WS, Ortonne J-P (eds): The Pigmentary System: Physiology and Pathophysiology, ed 2. Blackwell, Malden, 2006, pp 551-598.
2. Hann S-K, Nordlund J: Vitiligo. Oxford, Blackwell Science, 2000.
3. Howitz J, Brodthagen H, Schwartz M, Thompsen K: Prevalence of vitiligo: epidemiological survey of the Isle of Bornholm, Denmark. Arch Dermatol 1977;113:47-52.
4. Das SK, Majumder PP, Chakraborty R, Majumdar TK, Halder B: Studies on vitiligo. I. Epidemiological profile in Calcutta, India. Genet Epidemiol 1985;2:71-78.
5. Lu T, Gao T, Wang A, Jin Y, Li Q, Li C: Vitiligo prevalence study in Shaanxi Province, China. Int J Dermatol 2007;46:47-51.
6. Taieb A, Picardo M; VETF Members: The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res 2007;20:27-35.
7. Spritz RA, Chiang P-W, Oiso N, Alkhateeb A: Human and mouse disorders of pigmentation. Curr Opin Genet Dev 2003;13:284-289.
8. Alkhateeb A, Stetler GL, Old W, Talbert J, Uhlhorn C, Taylor M, Fox A, Miller C, Dills DG, Ridgway EC, Bennett DC, Fain PR, Spritz RA: Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2. Hum Mol Genet 2002;11:661-667.
9. Mehta NR, Shah KC, Theodore C, Vyas VP, Patel AB: Epidemiological study of vitiligo in Surat area. Indian J Med Res 1973;61:145-154.
10. Carnevale A, Zavala C, Castillo VD, Maldonado RR, Tamayo L: Analisis genetico de 127 families con vitiligo. Rev Invest Clin 1980;32:37-41.
11. Hafez M, Sharaf L, Abd El-Nabi SM: The genetics of vitiligo. Acta Derm Venereol 1983;63: 249-251.
12. Das SK, Majumder PP, Majumder TK, Haldar B: Studies on vitiligo. II. Familial aggregation and genetics. Genet Epidemiol 1985;2:255-262.
13. Majumder PP, Das SK, Li CC: A genetical model for vitiligo. Am J Hum Genet 1988;43:119-125.
14. Bhatia PS, Mohan L, Pandey ON, Singh KK, Arora SK, Mukhija RD: Genetic nature of vitiligo. J Dermatol Sci 1992;4:180-184.
15. Majumder PP, Nordlund JJ, Nath SK: Pattern of familial aggregation of vitiligo. Arch Dermatol 1993;129:994-998.
16. Nath SK, Majumder PP, Nordlund JJ: Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994;55:981-990.
17. Alkhateeb A, Fain PR, Thody A, Bennett DC, Spritz RA: Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their relatives. Pigment Cell Res 2003;16:208-214.
18. Sun X, Xu A, Wei X, Ouyang J, Lu L, Chen M, Zhang D: Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China. Int J Dermatol 2006;45:1176-1181.
19. Laberge G, Mailloux CM, Gowan K, Holland P, Bennett DC, Fain PR, Spritz RA: Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res 2005;18:300-305.
20. Harsoulis P, Kanakoudi-Tsakalidis F, Vyzantiadis A, Minas A, Cassimos C: Autoimmunity and vitiligo. Arch Dermatol 1978;114:1554.
21. Ongenae K, Van Geel N, Naeyaert J-M: Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res 2003;16:90-100.
22. Le Poole CI, Wankowicz-Kalinska A, van den Wijngaard RMJGJ, Nickoloff BJ, Das DK: Autoimmune aspects of depigmentation in vitiligo. J Investig Dermatol Symp Proc 2004;9:68-72.
23. Kemp EH, Gavalas NG, Gawkrodger DJ, Weetman AP: Autoantibody responses to melanocytes in the depigmenting skin disease vitiligo. Autoimmun Rev 2007;6:138-142.
24. Ogg GS, Rod Dunbar P, Romero P, Chen JL, Cerundolo V: High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J Exp Med 1998;188:1203-1208.
25. Gross A, Tapia FJ, Mosca W, Perez RM, Briceno L, Henriquez JJ, Convit J: Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromicum perstans and vitiligo. Histol Histopathol 1987;2:277-283.
26. Badri AM, Todd PM, Garioch JJ, Gudgeon JE, Stewart DG, Goudie RB: An immunohistological study of cutaneous lymphocytes in vitiligo. J Pathol 1993;170:149-155.
27. Le Poole IC, van den Wijngaard RM, Westerhof W, Das PK: Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am J Pathol 1996;148: 1219-1228.
28. Cunliffe W, Hall R, Newell J, Stevenson CJ: Vitiligo, thyroid disease and autoimmunity. Br J Dermatol 1968;80:135-139.
29. Schallreuter KW, Lemke R, Brandt O, Schwartz R, Westhofen M, Montz R, Berger J: Vitiligo and other diseases: coexistence or true association? Hamburg study on 321 patients. Dermatology 1994;188:269-275.
30. Dawber R: Integumentary associations of pernicious anemia. Br J Dermatol 1969;82:221-222.
31. Grunnet I, Howitz J: Vitiligo and pernicious anemia. Arch Dermatol 1979;101:82-85.
32. Zelissen PMJ, Bast EJEG, Croughs RJM: Associated autoimmunity in Addison's disease. J Autoimmun 1995;8:121-130.
33. Sharma VK, Dawn G, Kumar B: Profile of alopecia areata in Northern India. Int J Dermatol 1996;35:22-27.
34. Sharma VK, Kumar V, Dawn G: A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol 1996;13:372-377.
35. Handa S, Kaur I: Vitiligo: clinical findings in 1,436 patients. J Dermatol 1999;26:653-657.
36. Handa S, Dogra S: Epidemiology of childhood vitiligo: a study of 625 patients from north India. Pediatr Dermatol 2003;20:207-210.
37. Onunu AN, Kubeyinje EP: Vitiligo in the Nigerian African: a study of 351 patients in Benin City, Nigeria. Int J Dermatol 2003;42:800-802.
38. Le Poole IC, Sarangarajan R, Zhao Y, Stennett LS, Brown TL, Sheth P, Miki T, Boissy RE: 'VIT1', a novel gene associated with vitiligo. Pigment Cell Res 2001;14:475-484.
39. Kingo K, Philips MA, Aunin E, Luuk H, Karelson M, Ratsep R, Silm H, Vasar E, Koks S: MYG1, novel melanocyte related gene, has elevated expression in vitiligo. J Dermatol Sci 2006;44: 119-122.
40. Foley LM, Lowe NJ, Misheloff E, Tiwari JL: Association of HLA-DR4 with vitiligo. J Am Acad Dermatol 1983;8:39-40.
41. Finco O, Cuccia M, Mantinetti M, Ruberto G, Orecchia G, Rabbiosi G: Age of onset in vitiligo: relationship with HLA supratypes. Clin Genet 1991;39:448-454.
42. Orecchia G, Perfetti L, Malagoli P, Borghini F, Kipervarg Y: Vitiligo is associated with a significant increase in HLA-A30, Cw6 and Dqw3 and a decrease in C4AQ0 in northern Italian patients. Dermatology 1992;185:123-127.
43. Ando I, Chi HI, Nakagawa H, Otsuka F: Difference in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol 1993;129:408-410.
44. Schallreuter KU, Levenig C, Kuhnl P, Loliger C, Hohl-Tehari M, Berger J: Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from northern Germany. Dermatology 1993;187:186-192.
45. al-Fouzan A, al-Arbash M, Fouad F, Kaaba SA, Mousa MA, al-Harbi SA: Study of HLA class I/IL and T lymphocyte subsets in Kuwaiti vitiligo patients. Eur J Immunogenet 1995;22:209-213.
46. Zamani M, Spaepen M, Sghar SS, Huang C, Westerhof W, Nieuweboer-Krobotova L, Cassiman JJ: Linkage and association of HLA class II genes with vitiligo in a Dutch population. Br J Dermatol 2001;145:90-94.
47. Arcos-Burgos M, Parodi E, Salgar M, Bedoya E, Builes JJ, Jaramillo D, Ceballos G, Uribe A, Rivera N, Rivera D, Fonseca I, Camargo M, Palacio LG: Vitiligo: complex segregation and linkage disequilibrium analyses with respect to microsatellite loci spanning the HLA. Hum Genet 2002;110:334-342.
48. Tastan HB, Akar A, Orkunoglu FE, Arca E, Inal A: Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population. Pigment Cell Res 2004;17:181-184.
49. Xia Q, Zhou WM, Liang YH, Ge HS, Liu HS, Wang JY, Gao M, Yang S, Zhang XJ: MHC haplotypic association in Chinese Han patients with vitiligo. J Eur Acad Dermatol Venereol 2006;20:941-946.
50. Liu JB, Li M, Chen H, Zhong SQ, Yang S, Du WD, Hao JH, Zhang TS, Zhang XJ, Zeegers M: Association of vitiligo with HLA-A2: a meta-analysis. J Eur Acad Dermatol Venereol 2007;21:205-213.
51. Fain PR, Babu SR, Bennett DC, Spritz RA: HLA class II haplotype DRB1*04-DQB1*0301 contributes to risk of familial generalized vitiligo and early disease onset. Pigment Cell Res 2006;19:51-57.
52. Casp CB, She JX, McCormack WT: Genes of the LMP/TAP cluster are associated with the human autoimmune disease vitiligo. Genes Immun 2003;4:492-499.
53. Chen JJ, Huang W, Gui JP, Yang S, Zhou FS, Xiong OG, Wu HB, Cui Y, Gao M, Li W, Li JZ, Yan KL, Yuan WT, Xu SJ, Liu JJ, Zhang XJ: A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families. Am J Hum Genet 2005;76:1057-1065.
54. De la Fuente-Fernandez R: Mutations in GTP-cyclohydrolase I gene and vitiligo. Lancet 1997;350:640.
55. Bandyopadhyay D, Lawrence E, Majumder PP, Ferrell RE: Vitiligo is not caused by mutations in GTP-cyclohydrolase I gene. Clin Exper Dermatol 2000;25:152-153.
56. Casp CB, She JX, McCormack WT: Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res 2002;15:62-66.
57. Gavalas NG, Akhtar S, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH: Analysis of allelic variants in the catalase gene in patients with the skin depigmenting disorder vitiligo. Biochem Biophys Res Commun 2006;14;345:1586- 1591.
58. Park HH, Ha E, Uhm YK, Jin SY, Kim YJ, Chung JH, Lee MH: Association study between catalase gene polymorphisms and the susceptibility to vitiligo in Korean population. Exp Dermatol 2006;15:377-380.
59. Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Hong SJ, Park HK, Chung JH, Lee MH: Association of angiotensin converting enzyme gene I/D polymorphism of vitiligo in Korean population. Pigment Cell Res 2004;17:84-86.
60. Akhtar S, Gavalas NG, Gawkrodger DJ, Watson PF, Weetman AP, Kemp EH: An insertion/deletion polymorphism in the gene encoding angiotensin converting enzyme is not associated with generalised vitiligo in an English population. Arch Dermatol Res 2005;297:94-98.
61. Jin SY, Park HH, Li GZ, Lee HJ, Hong MS, Park HJ, Park HK, Seo JC, Yim SV, Chung JH, Lee MH: Association of estrogen receptor 1 intron 1 C/T polymorphism in Korean vitiligo patients. J Dermatol Sci 2004;35:181-186.
62. Tursen U, Kaya TI, Erdal ME, Derici E, Gunduz O, Ikizoglu G: Association between catechol-O-methyltransferase polymorphism and vitiligo. Arch Dermatol Res 2002;294:143-146.
63. Birlea S, Birlea M, Cimponeriu D, Apostol P, Cosgarea R, Gavrila L, Tigan S, Costin G, Das P: Autoimmune diseases and vitamin D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian community. Acta Derm Venereol 2006;86:209-214.
64. Blomhoff A, Kemp EH, Gawkrodger DJ, Weetman AP, Husebye ES, Akselsen HE, Lie BA, Undlien DE: CTLA4 polymorphisms are associated with vitiligo, in patients with concomitant autoimmune diseases. Pigment Cell Res 2005;18:55-58.
65. Canton I, Akhtar S, Gavalas NG, Gawkrodger DJ, Blomhoff A, Watson PF, Weetman AP, Kemp EH: A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun 2005;6:584-587.
66. Onay H, Pehlivan M, Alper S, Ozkinay F, Pehlivan S: Might there be a link between mannose binding lectin and vitiligo? Eur J Dermatol 2007;17:146-148.
67. Brand O, Gough S, Heward J: HLA, CTLA-4, and PTPN22: the shared genetic master-key to autoimmunity? Expert Rev Mol Med 2005;7:1-15.
68. Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ: Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation. Pigment Cell Res 1999;12:187-192.
69. Nath SK, Kelly JA, Namjou B, Lam T, Bruner GR, Scofield RH, Aston CE, Harley JB: Evidence for a susceptibility gene, SLEV1, on chromosome 17p13 in families with vitiligo-related systemic lupus erythematosus. Am J Hum Genet 2001;69:1401-1406.
70. Alkhateeb A, Fain PR, Spritz RA: Candidate functional promoter variant in the FOXD3 melanoblast developmental regulator gene in a family with autosomal dominant vitiligo. J Invest Dermatol 2005;125:388-391.
71. Fain PR, Gowan K, LaBerge GS, Alkhateeb A, Stetler GL, Talbert J, Bennett DC, Spritz RA: A genomewide screen for generalized vitiligo: confirmation of AIS1 on chromosome 1p31 and evidence for additional susceptibility loci. Am J Hum Genet 2003;72:1560-1564.
72. Spritz RA, Gowan K, Bennett DC, Fain PR: Novel vitiligo susceptibility loci on chromosomes 7 (AIS2) and 8 (AIS3), confirmation of SLEV1 on chromosome 17, and their roles in an autoimmune diathesis. Am J Hum Genet 2004;74:188-191.
73. Ying J, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA: NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med 2007;356:1216-1225.
74. Johansson CM, Zunec R, Garcia MA, Scherbarth HR, Tate GA, Paira S, Navarro SM, Perandones CE, Gamron S, Alvarellos A, Graf CE, Manni J, Berbotto GA, Palatnik SA, Catoggio LJ, Battagliotti CG, Sebastiani GD, Migliaresi S, Galeazzi M, Pons-Estel BA, Alarcon-Riqauelme ME; Collaborative Group on the Genetics of SLE; Argentine Collaborative Group: Chromosome 17p12-q11 harbors susceptibility loci for systemic lupus erythematosus. Hum Genet 2004;115: 230-238.
75. Jin Y, Birlea SA, Fain PR, Spritz RA: Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J Invest Dermatol 2007;127:2558-2562.